HCPLive Network
Latest Hospital Medicine Headlines
Friday, November 21, 2014
By Catherine Kolonko
The maker of Sovriad (simeprevir) has revised the drug's package insert labeling on the order of Japanese health officials following the deaths of three people who took the hepatitis C drug.
Friday, November 21, 2014
By Adam Hochron
As the technology of 3-D printing improves its uses are also growing. This includes creating more accurate models of patient hearts that can help surgeons with their work before ever making the first cut.
Friday, November 21, 2014
By Catherine Kolonko
Patients with cirrhosis who took part in a study that tested a triple combination drug for hepatitis C with ribavirin saw normalization of key laboratory tests after three and six month treatment periods, an indication of improved liver condition.
Thursday, November 20, 2014
By Adam Hochron
With a limited donor pool every minute and every decision made by pediatric transplant surgeons can make the difference between life and death for their patients. A recent study looked at whether there was a new way to look at who should be eligible for a heart transplant.
Thursday, November 20, 2014
By HCPLive staff
Study results show good outcomes for hip replacement in patients under age 35 diagnosed with juvenile idiopathic arthritis who have failed to respond to previous treatment.
Thursday, November 20, 2014
By HCPLive staff
Study results show that patients diagnosed with rheumatoid arthritis and who are either significantly underweight or overweight/obese have lower sustained remission rates compared with their normal weight counterparts.
Thursday, November 20, 2014
By Richard Robinson
A “biosimilar” form of etanercept is clinically equivalent to the branded form for rheumatoid arthritis, according to data presented at the 2014 annual meeting of the American College of Rheumatology.
Thursday, November 20, 2014
By Richard Robinson
A blood test may offer a reliable way to identify rheumatoid arthritis patients who are unlikely to respond to anti-tumor necrosis factor-alpha inhibitors, speeding treatment with other drugs and lowering costs.
Thursday, November 20, 2014
By Adam Hochron
As hospitals around the country deal with the newly instituted readmission penalties many are having to look at how they will handle providing the same level of care without some of the money they counted on in the past.
Wednesday, November 19, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Clinicians who see their own clinical outcomes data (sometimes referred to as surgeon-specific mortality data) can use that information to promote and enhance patient safety. However, critics of this approach argue that places the burden solely on the surgeon and under-appreciates the surgical team’s role and dismisses hospital staffing, infrastructure, and process as contributors to patient safety.
Email Signup
Physician's Money Digest
“Black Friday” has become a misnomer, with most big chain stores opening their doors – and their sales – on Thursday evening. It also turns out that Walmart and Target are no longer the kings of Black Friday, at least when it comes to having the largest markdowns.
Only if you know where to shop, goes the old punch line. But a recent Wall Street Journal article cites new research on the long-argued subject that is worth riffing upon.